Overall, most studies point to an effect of NZ on the attenuation of microgliosis by reducing the activated M1 microglia response in various disease models, such as in the APP1/PS1 mouse model of AD [284] and in EAE mice [285]. Here, PSEN1 is linked to Alzheimer disease.